LEWIS A. KAPLAN, District Judge.
In light of previous rulings, all that remains of these cases are (1) the ERISA claims of plaintiff Kocourek to the extent that they rest on alleged violations of the Shadow Stock Plan (the "SSP"),
Kocourek argues that (1) the state court decided the effect of the release under state law, not ERISA, and that he therefore is not collaterally estopped from litigating its validity here, (2) he did not voluntarily and knowingly release his claims as required under ERISA, and (3) defendants may not recover attorneys' fees, even if they can prove their counterclaims.
For the reasons set forth below, the Court (1) grants defendants' motion for summary judgment dismissing Kocourek's remaining claims, but (2) denies it as to defendants' counterclaims.
Kocourek was an employee of BAH from 1987 through 2007, when he retired. During his employment, Kocourek received "shadow stock" units through BAH's SSP.
On July 31, 2008, The Carlyle Group purchased a majority interest in BAH's U.S. government consulting business (the "Carlyle Transaction"). BAH stockholders received $797 per share of common stock they held at the time of the transaction. The merger agreement between Carlyle and BAH required that shareholders electing to sell their common stock in the transaction execute a letter of transmittal (the "LOT"). The LOT provided in relevant part that
Kocourek executed the LOT, tendered his shares, and received $22 million in the Carlyle Transaction.
Five days after executing the LOT, Kocourek sued BAH in New York state court, asserting claims for breach of contract, unjust enrichment, fraud, and equitable fraud related to his shadow stock units. In December 2009, while that action was pending, Kocourek filed suit in this court based on his holdings of shadow stock units and BAH common stock. This Court consolidated his case with two others brought by former BAH officers which asserted similar claims. Plaintiffs filed a consolidated complaint in September 2010.
On February 15, 2012, the Court granted in part defendants' motion to dismiss. The only claims that survived the Court's opinion were those brought by Kocourek based on alleged violations of ERISA relating to the SSP.
On September 10, 2012, the New York County Supreme Court heard oral argument on BAH's motion to dismiss Kocourek's second amended complaint in the state court action. Defendants argued that Kocourek's claims were barred by the release in the LOT. Kocourek argued that the release was unenforceable, or, in the alternative, that claims based on his shadow stock units were carved out of the release. The state court granted BAH's motion to dismiss, holding that the release was valid and barred Kocourek from litigating his claims based on BAH common stock or shadow stock units.
Kocourek filed a motion for clarification and reargument of the state court's decision as well as for leave to file an amended complaint. He sought to clarify whether the court had applied state or federal law in determining that the release barred his claims and also to amend his complaint to assert ERISA claims. The state court granted Kocourek's request for clarification and stated that it had applied state law in determining that the release barred his shadow stock unit-based contract claims. The court denied Kocourek leave to file a third amended complaint, holding that the ERISA claims Kocourek sought to add were duplicative of those he asserts here and that the state court would defer to this Court in the application of ERISA.
Defendants now move for summary judgment dismissing all of Kocourek's remaining claims in this action, arguing that (1) Kocourek is collaterally estopped to deny the validity of the release, as that issue was fully litigated and determined against him in the state court proceeding, and (2) even if the state court had not resolved the issue of the release, the plain language of the release makes clear that it bars Kocourek's remaining claims. With respect to the collateral estoppel argument, defendants contend that, even if the state court applied state law to determine that the release barred Kocourek's claims, the facts necessary to the state court dismissal are dispositive of the ERISA claims and they resolve this case. Defendants seek also partial summary judgment on its counterclaims for breach of contract, arguing that Kocourek's assertion of the released claims breached his obligation pursuant to the release not to bring suit.
Kocourek contends that he is not collaterally estopped with respect to the release because the state court applied state law to determine that the release barred his state law claims. Moreover, he argues that summary judgment on the validity of the release should be denied because material issues of fact exist as to whether Kocourek knowingly and voluntarily surrendered his rights to his with respect to his shadow stock units.
The preclusive effect of a New York state court's decision is governed by New York law.
Kocourek contends that he did not have a full and fair opportunity to litigate the validity of the release in the state court proceeding on the following theory:
Because the state court decision "makes no reference to any issues extrinsic to the four corners of the [LOT], as the Federal standard of review requires," Kocourek argues, that court did not consider anything beyond the LOT as supposedly required under ERISA. Thus, he contends, he is not collaterally estopped from challenging the validity of the release in federal court.
Defendants argue that "there is no substantive distinction between the arguments considered and decided by the state court and the Second Circuit law governing the release of ERISA claims."
Kocourek is correct that, under New York law, "a written agreement that is complete, clear and unambiguous on its face must be enforced according to the plain meaning of its terms."
Despite the fact that the state court applied state law in determining that the release barred Kocourek's state law claims, defendants are correct that collateral estoppel bars Kocourek from relitigating the validity of the release.
First, it is clear from the briefs submitted to the state court as well as the transcript of the hearing there that the parties argued and the court considered whether the release had been "knowing and voluntary" — the precise question courts must answer in determining whether a release of ERISA claims is valid. Indeed, Kocourek's counsel argued to the state court judge that the standard for determining whether a claim was validly released is "whether or not [one] knowingly, voluntarily signed a release and released away rights."
Second, defendants are correct that neither in their briefs or at oral argument did the parties argue that the parol evidence rule applied to the state court's determination whether the release was valid. Nor did the state court indicate that it had limited its analysis to the four corners of the LOT. Thus, the issue of whether the release was knowing and voluntary was "clearly raised in the [state court] action" and, although the state court did not elucidate the bases for its holding, it necessarily was "decided against" Kocourek.
Issue preclusion applies even where the claims litigated in the first proceeding were different from those litigated in the second.
Defendants would be entitled to summary judgment dismissing Kocourek's remaining claims even if Kocourek were not collaterally estopped on the issues of knowleged and voluntariness by the state court ruling.
"ERISA claims are validly waived as long as the waiver is knowing and voluntary under the totality of the circumstances."
It has "emphasize[d] [however,] that any attempt to establish a checklist of all applicable factors or to insist on rigid adherence to such a list is foreclosed by the very nature of the inquiry."
Kocourek does not deny that he was a sophisticated business executive, that he had retained counsel to sue BAH on the claims that were covered by the release before he signed that document,
First, Kocourek contends that the release's "principal deficiency is that the `clarity' element is not met."
This argument is flatly inconsistent with the clear terms of the release. It states that "[t]he undersigned . . . hereby releases and forever discharges BAH . . . from any and all claims . . . [or] cause of action . . . by reason of, relating to or arising from the fact that the undersigned is or was a stockholder of BAH . . . which the undersigned now has, has ever had, or may hereafter have against [BAH] whether or not relating to claims pending at . . . the Effective Time" of the merger.
Second, Kocourek notes that he received the LOT on July 24, 2008. The LOT recommended that he submit the completed document the next day to avoid delays in payment, which he did. So he contends that one day was insufficient time for him fully to review and consider the terms of the LOT.
The LOT quite plainly did not require that Kocourek return the completed document, assuming he decided to return it at all, within one day of his having received it. It merely recommended that he do so in order to avoid delay in receiving cash for his stock. The LOT's instruction section stated (in bold, capital letters) that the company "recommend[s] that you submit your completed letter of transmittal as soon as possible, and no later than Friday, July 25, 2008. Delays in submitting your letter of transmittal may result in delays in your receipt of your merger consideration."
Third, Kocourek contends that further discovery is necessary to determine who prepared the LOT and "what such bank intended respecting the release language."
Kocourek is an experienced businessman. He was a senior officer of BAH. He has retained counsel and sued BAH in two different proceedings. He acknowledged that he read and agreed to the terms of the LOT, which clearly state that, by tendering his shares in BAH, he was releasing all claims against the company. Kocourek could have chosen to retain his claims and exercise his appraisal rights. But he preferred to cash in on the $22 million that was offered in exchange for the release and his shadow stock units. The suggestion that he should not be bound by the agreement he signed because he did not understand it, or because he did not have ample time to review it, would be meritless without regard to any issue preclusion.
Defendants have asserted counterclaims against Kocourek for breach of contract and breach of the implied covenant of good faith and fair dealing. They contend that Kocourek had a contractual obligation not to assert the claims he released when he executed the LOT.
Kocourek does not dispute that he breached a contract and the covenant of good faith and fair dealing. He argues only that summary judgment should not be granted because defendants are not entitled to attorney fees under the American Rule.
To establish a claim for breach of contract under Delaware law,
Delaware courts consider "[a] release [to be] a form of contract with the consideration typically being the surrender of a claim or cause of action in exchange for the payment of funds or surrender or an offsetting claim."
Defendants counter that the Carlyle Group's offer was expressly contingent on the execution of the LOT. It is unreasonable to presume that the Carlyle Group would have paid the same amount for BAH's government practice if the shareholders had not extinguished their claims. And, had Kocourek chosen not to execute the LOT and tender his shares, his only option would have been to exercise his appraisal rights. Thus, in exchange for Kocourek's release of his claims, defendants paid Kocourek $22 million — an amount he would have received only upon execution of the LOT and release of his claims.
Notwithstanding that, under Delaware law, the release is considered a contract, and Kocourek breached the release by bringing his claims, the Court is not persuaded that defendants are entitled to summary judgment on their counterclaim for breach of contract. Defendants have failed to cite any cases in which a court has permitted a defendant to recover on this theory, and the Court is aware of only one. The Delaware Superior Court, in an unpublished opinion, wrote that:
But this Court finds more persuasive the view of the First Circuit, which held that "[a] release is an affirmative defense; it does not supply a defendant with an independent claim for breach of contract."
The implied covenant of good faith and fair dealing inheres in every contract and requires "a party in a contractual relationship to refrain from arbitrary or unreasonable conduct which has the effect of preventing the other party to the contract from receiving the fruits of the bargain."
The language in the release is specific and clear. By signing the LOT, Kocourek released his claims against BAH. Defendants do not allege that Kocourek breached any implied obligation in the LOT by bringing his lawsuits. Their claim for breach of the implied covenant of good faith and fair dealing — "a limited and extraordinary legal remedy" — therefore fails.
For the foregoing reasons, defendants' motion for summary judgment dismissing plaintiff Kocourek's remaining claims and for partial summary judgment in their counterclaims [DI 69] is granted to the extent that the remaining claims asserted in the second amended complaint are dismissed and otherwise denied. The consolidated complaint is dismissed in all respects.
SO ORDERED.